Zevia (ZVIA)
(Delayed Data from NYSE)
$1.05 USD
+0.03 (2.94%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $1.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Income Statements
Fiscal Year end for Zevia PBC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 166 | 163 | 138 | 110 | NA |
Cost Of Goods | 92 | 93 | 77 | 61 | NA |
Gross Profit | 75 | 70 | 61 | 50 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 104 | 118 | 149 | 55 | 0 |
Income After Depreciation & Amortization | -29 | -48 | -87 | -5 | 0 |
Non-Operating Income | 1 | 0 | 0 | -1 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -28 | -48 | -88 | -6 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | -7 | -14 | -42 | -6 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -28 | -48 | -88 | -6 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -21 | -34 | -46 | 0 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -27 | -46 | -86 | -5 | 0 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 1 | 1 | NA |
Income After Depreciation & Amortization | -29 | -48 | -87 | -5 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 50.62 | 41.74 | 34.45 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.41 | -0.81 | -1.33 | NA | NA |
Diluted Net EPS (GAAP) | -0.41 | -0.81 | -1.33 | NA | NA |
Fiscal Year end for Zevia PBC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 40.43 | 38.80 | 37.79 | 43.09 | 42.24 |
Cost Of Goods | 23.48 | 21.08 | 22.41 | 23.52 | 22.55 |
Gross Profit | 16.94 | 17.72 | 15.39 | 19.57 | 19.69 |
SG&A, R&D, and Dept/Amort Expenses | 24.01 | 25.00 | 24.28 | 30.99 | 25.07 |
Income After SG&A, R&D, and Dept/Amort Expenses | -7.07 | -7.28 | -8.89 | -11.42 | -5.38 |
Non-Operating Income | 0.14 | 0.10 | -0.24 | 0.17 | 0.40 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -6.93 | -7.19 | -9.13 | -11.26 | -4.97 |
Income Taxes | 0.03 | 0.01 | 0.02 | -0.01 | 0.04 |
Minority Interest | -1.07 | -1.38 | -1.90 | -3.03 | -1.08 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.96 | -7.20 | -9.15 | -11.25 | -5.01 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -5.89 | -5.82 | -7.26 | -8.22 | -3.93 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 58.65 | 55.89 | 52.22 | 50.76 | 50.09 |
Diluted EPS Before Non-Recurring Items | -0.09 | -0.10 | -0.14 | -0.16 | -0.08 |
Diluted Net EPS (GAAP) | -0.10 | -0.10 | -0.13 | -0.16 | -0.08 |